EN
enGene Holdings Inc. Warrants
ENGNW · NASDAQ
$0.20 -90.48% (-$1.90)
1M -20.06%
Market Cap $10.8M
P/E Ratio -
Div. Yield -
ROE 2.10%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.05x
P/E N/A
EV/FFO N/A
Growth
78 /100
Growing Book val. growth 9.59%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 1.61%
Asset turnover 0.00x
ROE 2.10%
Debt
69 /100
Low Debt/Equity 0.03x
Int. coverage -44.28x
Current ratio 9.79x
Stability
19 /100
Unstable Beta -0.28x
Profitable years 0
EPS volatility 128,900.54%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ENGNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ronald H. W. Cooper
Employees
82
Headquarters
Montreal
Nadcházející události
23 PRO
Earnings
Upcoming earnings report